Detalhe da pesquisa
1.
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.
Lancet
; 386(9997): 974-81, 2015 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26135706